Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Influenza

Free Subscription 08.12.2025 2 Antiviral Res 1 Biochem Biophys Res Commun 1 J Gen Virol 1 J Infect Dis 1 N Engl J Med 1 PLoS Med 8 PLoS One 1 Proc Natl Acad Sci U S A 15 Vaccine 4 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. XIONG R, Wu Y, Wang Y, Qu Z, et al
   Rapid generation of a murine RSV infectious model by transducing a conditional knock-in mouse harboring human IGF1 receptor with adenoviral vector.
   Antiviral Res. 2025;244:106304.
   PubMed         Abstract available
   
   
2. SUTTO-ORTIZ P, Selisko B, Ferron F, Sommadossi JP, et al
   Mapping the impact of 1'-, 2'- and 4'-nucleotide modifications on the Respiratory Syncytial Virus RNA-dependent RNA polymerase.
   Antiviral Res. 2025;244:106298.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

3. MOHAMMED A, Ibrahim NA, Basher NS
   Innovations and challenges in vaccine development: Lessons from the SARS-CoV-2 pandemic and prospects.
   Biochem Biophys Res Commun. 2025;792:152947.
   PubMed         Abstract available
   
   

   
   J Gen Virol

4. METAXAKI M, Ram R, Perera M, Wills M, et al
   Robust antibody and T cell responses tracked longitudinally in patients with long COVID.
   J Gen Virol. 2025;106:002172.
   PubMed         Abstract available
   
   

   
   J Infect Dis

5. SUMNER KM, Katz M, Hirsch A, Peretz A, et al
   Improved immune response against influenza A viruses with receipt of a recombinant influenza vaccine in healthcare personnel with prior low antibody response to egg-based influenza vaccines, Israel, 2019-20.
   J Infect Dis. 2025 Dec 3:jiaf605. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   N Engl J Med

6. GUAN L, Pattinson D, Eisfeld AJ, Wang T, et al
   Stability of Avian Influenza A(H5N1) Virus in Milk from Infected Cows and Virus-Spiked Milk.
   N Engl J Med. 2025;393:2271-2273.
   PubMed        
   
   

   
   PLoS Med

7. HEITKAMP P, Chijioke-Akaniro O, Pai M
   From dependence to self-reliance: The future of the global tuberculosis response.
   PLoS Med. 2025;22:e1004824.
   PubMed         Abstract available
   
   

   
   PLoS One

8. SVENSSON AM, Bjornson M, Skold M, Kauczor HU, et al
   Pulmonary vascular and airway changes in previously hospitalised COVID-19 patients: Long-term functional respiratory imaging findings correlate with reduced DLCO.
   PLoS One. 2025;20:e0335075.
   PubMed         Abstract available
   
   
9. DOI L, Morrison K, Anago EK, Hughes T, et al
   Evaluation of the delivery of the family nurse partnership programme in Scotland during the COVID-19 pandemic.
   PLoS One. 2025;20:e0337080.
   PubMed         Abstract available
   
   
10. EL-AKKAD SE, Shao S, Tran KC, Naik H, et al
    Association between COVID-19 vaccination, SARS-CoV-2 variants, and post COVID-19 condition: A cross-sectional study.
    PLoS One. 2025;20:e0336929.
    PubMed         Abstract available
    
    
11. RAHIMIPOUR ANARAKI N, Mukhopadhyay M, Patey C, Norman P, et al
    Factors Iinfluencing SurgeCon Implementation in Four Canadian Emergency Departments Guided by Consolidated Framework for Implementation Research.
    PLoS One. 2025;20:e0337389.
    PubMed         Abstract available
    
    
12. SHEIKH F, Dolovich M, Schwartz L, Khan S, et al
    Evaluating N95 respirator designs: A mixed-methods pilot and feasibility study.
    PLoS One. 2025;20:e0328746.
    PubMed         Abstract available
    
    
13. LEET DE, Jin J, Craik CS, Kattah MG, et al
    Post-vaccination SARS-CoV-2 neutralizing antibodies in pregnant women receiving biologics for inflammatory bowel disease.
    PLoS One. 2025;20:e0321242.
    PubMed         Abstract available
    
    
14. SAMA SR, Gore R, Bauer AZ, Garber L, et al
    Autoimmune diseases as pre-existing conditions and sequelae of post COVID-19 condition in a Massachusetts community based observational study of COVID-19 patients.
    PLoS One. 2025;20:e0337848.
    PubMed         Abstract available
    
    
15. HAMADOU M, Bakwo Bassogog CB, Obadias FV, Assaly AD, et al
    Moringa oleifera potential for the treatment and prevention of COVID-19 involving molecular interaction, antioxidant properties and kinetic mechanism.
    PLoS One. 2025;20:e0337904.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

16. JAMIESON KH, Gibson LA, Jamieson PE, Patterson S Jr, et al
    Using a mental model approach to undercut the effects of exposure to mRNA vaccination misconceptions: Two randomized trials.
    Proc Natl Acad Sci U S A. 2025;122:e2517067122.
    PubMed         Abstract available
    
    

    
    Vaccine

17. GENSOROWSKY D, Surmann B, Meyer AC, Poshtiban A, et al
    Outpatient care intensity and influenza vaccination: evidence from Germany.
    Vaccine. 2025;70:128038.
    PubMed         Abstract available
    
    
18. FILIPE JAN, Wong CKH, van Leeuwen E, Goodfellow L, et al
    A systematised review of seasonal influenza case-fatality risk.
    Vaccine. 2025;60 Suppl 2:128011.
    PubMed         Abstract available
    
    
19. COOPER SC, Williams IV, Porter A, Presti C, et al
    'They're not going to tell you everything': A qualitative study with HPV vaccine hesitant parents and caregivers in the northeast and southeast U.S.
    Vaccine. 2025;68:127948.
    PubMed         Abstract available
    
    
20. DEVSAM B, Bortolussi K, Tippins J, Vasiliadis S, et al
    The experience of seeking & granting special medical exemptions for mandated vaccines: A scoping review.
    Vaccine. 2025;68:127935.
    PubMed         Abstract available
    
    
21. TALESHI J, Paramo MV, Watts A, Chilvers M, et al
    Cost-effectiveness of infant and maternal RSV immunization strategies, in British Columbia, Canada.
    Vaccine. 2025;68:127936.
    PubMed         Abstract available
    
    
22. GARVEY K, Salmon DA, Dudley MZ, Brewer J, et al
    Associations between trust in public health, vaccine confidence, and COVID-19 vaccination among American adults.
    Vaccine. 2025;68:127955.
    PubMed         Abstract available
    
    
23. COUTO P, Campbell H, Li Y, Rondy M, et al
    Implications of respiratory syncytial virus seasonality for the timing of passive immunisation scenarios in Latin America and the caribbean - a cross-sectional modelling study.
    Vaccine. 2025;68:127934.
    PubMed         Abstract available
    
    
24. BICEGO A, Wood JG, Newall AT, Hogan AB, et al
    Effectiveness of maternal vaccines and long-acting monoclonal antibodies against respiratory syncytial virus disease burden in early life: a scoping review of dynamic modelling studies.
    Vaccine. 2025;68:127868.
    PubMed         Abstract available
    
    
25. GROMER DJ, Kalash S, Tanios R, Rouphael N, et al
    The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review.
    Vaccine. 2025;68:127892.
    PubMed         Abstract available
    
    
26. REINHOLM A, Khan H, Laakso T, Maljanen S, et al
    Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1.
    Vaccine. 2025;68:127894.
    PubMed         Abstract available
    
    
27. THAWEETHAI T, Gross RS, Pant DB, Rhee KE, et al
    Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection.
    Vaccine. 2025;68:127907.
    PubMed         Abstract available
    
    
28. SAITO T, Couzinet A, Suzuki T, Shimomura M, et al
    Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms.
    Vaccine. 2025;68:127942.
    PubMed         Abstract available
    
    
29. ZHANG Q, Lewis KB, Phillips JC, Ma H, et al
    Decisional needs of older adults considering COVID-19 booster vaccinations: A systematic review comparing China with other countries.
    Vaccine. 2025;68:127949.
    PubMed         Abstract available
    
    
30. ZIDAN M, Trinh NTH, Desalegn A, Smith LH, et al
    BNT162b2 mRNA COVID-19 vaccine effectiveness in pregnancy: Emulating trial NCT04754594 using observational data from Norwegian health registries.
    Vaccine. 2025;68:127908.
    PubMed         Abstract available
    
    
31. O'BRIEN TL, Johnson DR
    U.S. state lawmaker support for COVID-19 vaccine policies during the pandemic.
    Vaccine. 2025;68:127930.
    PubMed         Abstract available
    
    

    
    Virology

32. JEFFREE CE, Lu TB, Tan BH, Sugrue RJ, et al
    Analysis of the surface topology of respiratory syncytial virus particles that form on the surface of virus-infected cells.
    Virology. 2026;614:110732.
    PubMed         Abstract available
    
    
33. GARRY RF
    SARS-CoV-2 Spike displays multiple adaptive changes in addition to the furin cleavage site.
    Virology. 2026;614:110720.
    PubMed         Abstract available
    
    
34. POPOVIC ME, Stevanovic M, Tadic V
    COVID-19 ante portas: Empirical formula, growth reactions and thermodynamic properties of biosynthesis and antigen-receptor binding of the Omicron XFG variant of SARS-CoV-2.
    Virology. 2026;614:110742.
    PubMed         Abstract available
    
    
35. RIVETTI AV JR, Reischak D, Carnegie L, Otaka JNP, et al
    Genomic diversity and reassortment of highly pathogenic avian influenza A/H5N1 virus (clade 2.3.4.4b) in Brazil: Evidence of multiple introductions and intra-epidemic reassortment in 2025.
    Virology. 2025;615:110751.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.